[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Genmab Genmab Genmab posts on X about $abbv, virtual, the first, science the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::4353611175/interactions)  - X Week XXXXX +607% - X Month XXXXX -XX% - X Months XXXXXX -XX% - X Year XXXXXX +205% ### Mentions: XX [#](/creator/twitter::4353611175/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XX +30% - X Year XXX +228% ### Followers: XXXXX [#](/creator/twitter::4353611175/followers)  - X Week XXXXX +0.09% - X Month XXXXX -XXXX% - X Months XXXXX -XXXX% - X Year XXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::4353611175/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) **Social topic influence** [$abbv](/topic/$abbv) #62, [virtual](/topic/virtual), [the first](/topic/the-first), [science](/topic/science), [nhl](/topic/nhl) #1929, [if you](/topic/if-you), [eu](/topic/eu), [products](/topic/products), [to the](/topic/to-the), [vice](/topic/vice) **Top accounts mentioned or mentioned by** [@abbvie](/creator/undefined) [@kinatsofrim](/creator/undefined) [@usfda](/creator/undefined) [@ashhematology](/creator/undefined) [@asco](/creator/undefined) [@societyofhemonc](/creator/undefined) [@myesmo](/creator/undefined) [@johnshopkins](/creator/undefined) [@oncotarget](/creator/undefined) [@biontechgroup](/creator/undefined) [@bionjorg](/creator/undefined) [@emanews](/creator/undefined) [@eucommission](/creator/undefined) [@sgoorgs](/creator/undefined) [@aacr](/creator/undefined) [@cr4hope](/creator/undefined) [@stephanielieber](/creator/undefined) [@imermanangels](/creator/undefined) [@bloodcancerutd](/creator/undefined) [@checkorphan](/creator/undefined) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last XX hours "#ICYMI: Were focused on our commitment to our vision and strategic roadmap as we aim to innovate for the benefit of patients. At the heart of this journey are the patients. Their perspectives guide all we do at Genmab. We always want them to feel seen and heard. Hear from Daan Meester in this edition of #AntibodyHour 🕙 on how we keep patient perspectives at the forefront of drug development. #PatientFirst #Innovation" [X Link](https://x.com/Genmab/status/1993696255856566348) 2025-11-26T15:00Z 7976 followers, XXX engagements "We are looking forward to data presentations from Genmab programs at #SITC20. Visit our virtual booth from Nov 10-14 to get the latest information on our oncology research" [X Link](https://x.com/Genmab/status/1325868533218226176) 2020-11-09T18:31Z 7978 followers, XX engagements "If you are attending #ASH20 make sure to visit our virtual booth to learn more about data presentations from Genmab #oncology programs" [X Link](https://x.com/Genmab/status/1335222394328248322) 2020-12-05T14:00Z 7978 followers, XX engagements "Innovation means reshaping how we think and work. During this episode of #AntibodyHour 🕙 hear from Ewan Robson Senior Director EU Medical Affairs as he explains how controlled disruption fuels progress at Genmab. #Innovation #2030vision" [X Link](https://x.com/Genmab/status/1986086110385037475) 2025-11-05T15:00Z 7976 followers, XXX engagements "#InvestorUpdate: Genmab presented an update on our financial performance for the first nine months of 2025. This quarter we advanced our late-stage pipeline brought innovative antibody medicines to patients in new geographies on our own and continued our transformation into an integrated biotech. Check out our Q3 highlights:" [X Link](https://x.com/Genmab/status/1986494737826607302) 2025-11-06T18:03Z 7976 followers, XXX engagements "#NewsUpdate: The @US_FDA has approved a new indication for one of our antibody-based products developed with @AbbVie as a treatment option for adults with relapsed or refractory follicular #lymphoma. Read more:" [X Link](https://x.com/Genmab/status/1990826030362177644) 2025-11-18T16:54Z 7978 followers, XXX engagements "Congratulations to the team from @JohnsHopkins & Genmab on the recent publication in @Oncotarget. The article titled Selective amplification of hypermethylated DNA from diverse tumor types via MSRE-PCR was featured as a cover paper in this weeks issue" [X Link](https://x.com/Genmab/status/1331689228422569984) 2020-11-25T20:00Z 7977 followers, XX engagements "#InvestorUpdate Mark your calendar for November 6: Genmab will release our interim report for the first nine months of 2025. Join us to learn how were advancing our strategic priorities and delivering on our vision to become an integrated biotech company bringing innovative antibody medicines to patients. Register #Biotech #AntibodyScience #Innovation" [X Link](https://x.com/Genmab/status/1985772345920012434) 2025-11-04T18:13Z 7976 followers, XXX engagements "This #NationalFamilyCaregiversMonth Genmab honors the dedication of care partners. In this edition of #AntibodyHour 🕙 Leslie Amendola Senior Vice President and US General Managerreflects on her experience caring for her mother andhow understanding those experiences deepen Genmabs commitment to supporting patients and those who care for them. #PatientFirst #CarePartner" [X Link](https://x.com/Genmab/status/1988622824735736133) 2025-11-12T15:00Z 7976 followers, XXX engagements "Investor Update: Genmab President & CEO Jan van de Winkel will be participating in a fireside chat alongside EVP & CFO Anthony Pagano at the @Jefferies 2025 Conference where they will share Genmabs strategic direction innovation priorities and growth roadmap. The webcast will be available here: #Jefferies2025 #Biotech #InvestorRelations" [X Link](https://x.com/Genmab/status/1989332496798847184) 2025-11-14T14:00Z 7975 followers, XXX engagements "What sets Genmab apart is our deep connection between groundbreaking science and the patients we serve. During this edition of #AntibodyHour🕙 our colleague Shawn Keogan Director of Patient Advocacy shares how Genmabs people and purpose inspire her. #PatientFirst #Innovation" [X Link](https://x.com/Genmab/status/1991159531821539705) 2025-11-19T15:00Z 7976 followers, XXX engagements "Were excited to attend this years @ASH_hematology annual meeting (#ASH25) and look forward to presenting new data from our hematology portfolio to further our goal in bringing innovative antibody medicines to patients. To learn more stop by our booth #701 and visit:" [X Link](https://x.com/Genmab/status/1995862486394733009) 2025-12-02T14:27Z 7974 followers, XXX engagements "#InvestorUpdate: Join us virtually on December XX for our 2025 R&D Update and #ASH25 Data Review where well be offering insights into our antibody innovations and #hematology #pipeline. Register today: Please note that this event is not part of the official ASH Annual Meeting" [X Link](https://x.com/Genmab/status/1996603097108406465) 2025-12-04T15:30Z 7976 followers, XXX engagements "At #ASH2025 we will be presenting novel clinical data on subtypes of non-Hodgkin #lymphoma (NHL). NHL is a cancer of the lymphatic system typically found in lymph nodes. Learn more below" [X Link](https://x.com/Genmab/status/1996998111571370436) 2025-12-05T17:40Z 7976 followers, XXX engagements "We shared new data at the @ASH_hematology Annual Meeting evaluating one of our medicines as a monotherapy and in combination for diffuse large B-cell #lymphoma (#DLBCL) in collaboration with @abbvie. Read more: #ASH2025" [X Link](https://x.com/Genmab/status/1997357137433882838) 2025-12-06T17:27Z 7976 followers, XXX engagements "At the @ASH_hematology Annual Meeting we presented new data on our medicine for relapsed/refractory follicular #lymphoma in partnership with @abbvie. These findings were also published in @TheLancet. Read more: #ASH2025" [X Link](https://x.com/Genmab/status/1997654101547421866) 2025-12-07T13:07Z 7975 followers, XXX engagements "At the @ASH_hematology Annual Meeting we shared new data investigating one of our assets in collaboration with @abbvie for patients with Richter transformation (RT). Read more: #ASH2025" [X Link](https://x.com/Genmab/status/1998145906743341464) 2025-12-08T21:41Z 7975 followers, XXX engagements "As #ASH2025 concludes we remain focused on advancing research in non-Hodgkin #lymphoma (NHL) and related B-cell malignancies. Lets continue shaping the future of care to drive better patient outcomes" [X Link](https://x.com/Genmab/status/1998453743587619288) 2025-12-09T18:04Z 7975 followers, XXX engagements "At Genmab our purpose comes to life when we listen to patients. In this edition of #AntibodyHour 🕙werespotlighting Keith amember of our Patient Advisory Council. Keith shared that serving as a patient advisor has been really gratifying to be able to take his experience and share it in a constructive way. WeregratefulforKeithwho inspiresus andstrengthensour commitment to meaningful innovation in cancer. #PatientFirst #Innovation #PatientAdvocacy" [X Link](https://x.com/Genmab/status/1998769674050548089) 2025-12-10T15:00Z 7976 followers, XXX engagements "At Genmab our 25+ years of #antibodyexpertise fuels our vision to advance next generation #oncology therapies. Through proprietary technologies agile R&D and AI-powered insights we're breaking barriers in treatment #innovation with patients at the center of everything we do. The latest video in our R&D series showcases the science behind our discoveries:" [X Link](https://x.com/Genmab/status/1999161898604933456) 2025-12-11T16:58Z 7976 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Genmab Genmab
Genmab posts on X about $abbv, virtual, the first, science the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +607%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +205%
Mentions: XX #
- X Week XX -XX%
- X Month XX -XX%
- X Months XX +30%
- X Year XXX +228%
Followers: XXXXX #
- X Week XXXXX +0.09%
- X Month XXXXX -XXXX%
- X Months XXXXX -XXXX%
- X Year XXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence stocks finance
Social topic influence $abbv #62, virtual, the first, science, nhl #1929, if you, eu, products, to the, vice
Top accounts mentioned or mentioned by @abbvie @kinatsofrim @usfda @ashhematology @asco @societyofhemonc @myesmo @johnshopkins @oncotarget @biontechgroup @bionjorg @emanews @eucommission @sgoorgs @aacr @cr4hope @stephanielieber @imermanangels @bloodcancerutd @checkorphan
Top assets mentioned AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last XX hours
"#ICYMI: Were focused on our commitment to our vision and strategic roadmap as we aim to innovate for the benefit of patients. At the heart of this journey are the patients. Their perspectives guide all we do at Genmab. We always want them to feel seen and heard. Hear from Daan Meester in this edition of #AntibodyHour 🕙 on how we keep patient perspectives at the forefront of drug development. #PatientFirst #Innovation"
X Link 2025-11-26T15:00Z 7976 followers, XXX engagements
"We are looking forward to data presentations from Genmab programs at #SITC20. Visit our virtual booth from Nov 10-14 to get the latest information on our oncology research"
X Link 2020-11-09T18:31Z 7978 followers, XX engagements
"If you are attending #ASH20 make sure to visit our virtual booth to learn more about data presentations from Genmab #oncology programs"
X Link 2020-12-05T14:00Z 7978 followers, XX engagements
"Innovation means reshaping how we think and work. During this episode of #AntibodyHour 🕙 hear from Ewan Robson Senior Director EU Medical Affairs as he explains how controlled disruption fuels progress at Genmab. #Innovation #2030vision"
X Link 2025-11-05T15:00Z 7976 followers, XXX engagements
"#InvestorUpdate: Genmab presented an update on our financial performance for the first nine months of 2025. This quarter we advanced our late-stage pipeline brought innovative antibody medicines to patients in new geographies on our own and continued our transformation into an integrated biotech. Check out our Q3 highlights:"
X Link 2025-11-06T18:03Z 7976 followers, XXX engagements
"#NewsUpdate: The @US_FDA has approved a new indication for one of our antibody-based products developed with @AbbVie as a treatment option for adults with relapsed or refractory follicular #lymphoma. Read more:"
X Link 2025-11-18T16:54Z 7978 followers, XXX engagements
"Congratulations to the team from @JohnsHopkins & Genmab on the recent publication in @Oncotarget. The article titled Selective amplification of hypermethylated DNA from diverse tumor types via MSRE-PCR was featured as a cover paper in this weeks issue"
X Link 2020-11-25T20:00Z 7977 followers, XX engagements
"#InvestorUpdate Mark your calendar for November 6: Genmab will release our interim report for the first nine months of 2025. Join us to learn how were advancing our strategic priorities and delivering on our vision to become an integrated biotech company bringing innovative antibody medicines to patients. Register #Biotech #AntibodyScience #Innovation"
X Link 2025-11-04T18:13Z 7976 followers, XXX engagements
"This #NationalFamilyCaregiversMonth Genmab honors the dedication of care partners. In this edition of #AntibodyHour 🕙 Leslie Amendola Senior Vice President and US General Managerreflects on her experience caring for her mother andhow understanding those experiences deepen Genmabs commitment to supporting patients and those who care for them. #PatientFirst #CarePartner"
X Link 2025-11-12T15:00Z 7976 followers, XXX engagements
"Investor Update: Genmab President & CEO Jan van de Winkel will be participating in a fireside chat alongside EVP & CFO Anthony Pagano at the @Jefferies 2025 Conference where they will share Genmabs strategic direction innovation priorities and growth roadmap. The webcast will be available here: #Jefferies2025 #Biotech #InvestorRelations"
X Link 2025-11-14T14:00Z 7975 followers, XXX engagements
"What sets Genmab apart is our deep connection between groundbreaking science and the patients we serve. During this edition of #AntibodyHour🕙 our colleague Shawn Keogan Director of Patient Advocacy shares how Genmabs people and purpose inspire her. #PatientFirst #Innovation"
X Link 2025-11-19T15:00Z 7976 followers, XXX engagements
"Were excited to attend this years @ASH_hematology annual meeting (#ASH25) and look forward to presenting new data from our hematology portfolio to further our goal in bringing innovative antibody medicines to patients. To learn more stop by our booth #701 and visit:"
X Link 2025-12-02T14:27Z 7974 followers, XXX engagements
"#InvestorUpdate: Join us virtually on December XX for our 2025 R&D Update and #ASH25 Data Review where well be offering insights into our antibody innovations and #hematology #pipeline. Register today: Please note that this event is not part of the official ASH Annual Meeting"
X Link 2025-12-04T15:30Z 7976 followers, XXX engagements
"At #ASH2025 we will be presenting novel clinical data on subtypes of non-Hodgkin #lymphoma (NHL). NHL is a cancer of the lymphatic system typically found in lymph nodes. Learn more below"
X Link 2025-12-05T17:40Z 7976 followers, XXX engagements
"We shared new data at the @ASH_hematology Annual Meeting evaluating one of our medicines as a monotherapy and in combination for diffuse large B-cell #lymphoma (#DLBCL) in collaboration with @abbvie. Read more: #ASH2025"
X Link 2025-12-06T17:27Z 7976 followers, XXX engagements
"At the @ASH_hematology Annual Meeting we presented new data on our medicine for relapsed/refractory follicular #lymphoma in partnership with @abbvie. These findings were also published in @TheLancet. Read more: #ASH2025"
X Link 2025-12-07T13:07Z 7975 followers, XXX engagements
"At the @ASH_hematology Annual Meeting we shared new data investigating one of our assets in collaboration with @abbvie for patients with Richter transformation (RT). Read more: #ASH2025"
X Link 2025-12-08T21:41Z 7975 followers, XXX engagements
"As #ASH2025 concludes we remain focused on advancing research in non-Hodgkin #lymphoma (NHL) and related B-cell malignancies. Lets continue shaping the future of care to drive better patient outcomes"
X Link 2025-12-09T18:04Z 7975 followers, XXX engagements
"At Genmab our purpose comes to life when we listen to patients. In this edition of #AntibodyHour 🕙werespotlighting Keith amember of our Patient Advisory Council. Keith shared that serving as a patient advisor has been really gratifying to be able to take his experience and share it in a constructive way. WeregratefulforKeithwho inspiresus andstrengthensour commitment to meaningful innovation in cancer. #PatientFirst #Innovation #PatientAdvocacy"
X Link 2025-12-10T15:00Z 7976 followers, XXX engagements
"At Genmab our 25+ years of #antibodyexpertise fuels our vision to advance next generation #oncology therapies. Through proprietary technologies agile R&D and AI-powered insights we're breaking barriers in treatment #innovation with patients at the center of everything we do. The latest video in our R&D series showcases the science behind our discoveries:"
X Link 2025-12-11T16:58Z 7976 followers, XX engagements